These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19586593)

  • 1. The management of sickle cell pain.
    Richard RE
    Curr Pain Headache Rep; 2009 Aug; 13(4):295-7. PubMed ID: 19586593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sickle cell disease: What all PAs should know.
    Kayinqo G
    JAAPA; 2012 Sep; 25(9):19-20. PubMed ID: 22991882
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of sickle pain.
    Ballas SK
    Curr Opin Hematol; 1997 Mar; 4(2):104-11. PubMed ID: 9107526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sickle cell disease: taking a multidisciplinary approach.
    Apanah S; Rizzolo D
    JAAPA; 2013 Aug; 26(8):28-33. PubMed ID: 24049937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The vaso-occlusive pain crisis in sickle cell disease: Definition, pathophysiology, and management.
    Darbari DS; Sheehan VA; Ballas SK
    Eur J Haematol; 2020 Sep; 105(3):237-246. PubMed ID: 32301178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical care of adult patients with sickle cell disease.
    Olujohungbe A; Howard J
    Br J Hosp Med (Lond); 2008 Nov; 69(11):616-9. PubMed ID: 19069260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approach to the vaso-occlusive crisis in adults with sickle cell disease.
    Yale SH; Nagib N; Guthrie T
    Am Fam Physician; 2000 Mar; 61(5):1349-56, 1363-4. PubMed ID: 10735342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of sickle cell disease.
    Steinberg MH
    N Engl J Med; 1999 Apr; 340(13):1021-30. PubMed ID: 10099145
    [No Abstract]   [Full Text] [Related]  

  • 9. Frequency of Hospitalizations for Pain and Association With Altered Brain Network Connectivity in Sickle Cell Disease.
    Darbari DS; Hampson JP; Ichesco E; Kadom N; Vezina G; Evangelou I; Clauw DJ; Taylor Vi JG; Harris RE
    J Pain; 2015 Nov; 16(11):1077-86. PubMed ID: 26291276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and emerging treatments for sickle cell disease.
    Monus T; Howell CM
    JAAPA; 2019 Sep; 32(9):1-5. PubMed ID: 31460979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High inpatient dose of opioid at discharge compared to home dose predicts readmission risk in sickle cell disease.
    Han J; Saraf SL; Gowhari M; Jain S; Molokie RE; Gordeuk VR
    Am J Hematol; 2019 Jan; 94(1):E5-E7. PubMed ID: 30299555
    [No Abstract]   [Full Text] [Related]  

  • 12. The management of painful crisis in sickle cell disease.
    Wright J; Ahmedzai SH
    Curr Opin Support Palliat Care; 2010 Jun; 4(2):97-106. PubMed ID: 20440206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Phase 3 Trial of l-Glutamine in Sickle Cell Disease.
    Niihara Y; Miller ST; Kanter J; Lanzkron S; Smith WR; Hsu LL; Gordeuk VR; Viswanathan K; Sarnaik S; Osunkwo I; Guillaume E; Sadanandan S; Sieger L; Lasky JL; Panosyan EH; Blake OA; New TN; Bellevue R; Tran LT; Razon RL; Stark CW; Neumayr LD; Vichinsky EP;
    N Engl J Med; 2018 Jul; 379(3):226-235. PubMed ID: 30021096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sickle cell disease--pathophysiology and treatment.
    Redding-Lallinger R; Knoll C
    Curr Probl Pediatr Adolesc Health Care; 2006; 36(10):346-76. PubMed ID: 17055417
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of pain rehabilitation in an adolescent sickle cell disease population: a case series.
    Collins AB; McTate-Acosta EA; Williams SE
    Pediatr Hematol Oncol; 2020 Oct; 37(7):637-644. PubMed ID: 32401110
    [No Abstract]   [Full Text] [Related]  

  • 16. Pathogenesis and treatment of sickle cell disease.
    Bunn HF
    N Engl J Med; 1997 Sep; 337(11):762-9. PubMed ID: 9287233
    [No Abstract]   [Full Text] [Related]  

  • 17. Proportion of adults with sickle cell anemia and pain crises receiving hydroxyurea.
    Stettler N; McKiernan CM; Melin CQ; Adejoro OO; Walczak NB
    JAMA; 2015 Apr; 313(16):1671-2. PubMed ID: 25919532
    [No Abstract]   [Full Text] [Related]  

  • 18. Sickle cell disease in North Europe.
    Howard J; Davies SC
    Scand J Clin Lab Invest; 2007; 67(1):27-38. PubMed ID: 17365983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sickle cell pain crisis.
    Davies SC; Bevan DH
    Lancet; 1996 Jan; 347(8996):263. PubMed ID: 8551907
    [No Abstract]   [Full Text] [Related]  

  • 20. Sickle cell disease: new insights into pathophysiology and treatment.
    Inati A; Koussa S; Taher A; Perrine S
    Pediatr Ann; 2008 May; 37(5):311-21. PubMed ID: 18543542
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.